Company Filing History:
Years Active: 1996-1997
Title: Raji A Shankar: Innovator in Immunotherapy
Introduction
Raji A Shankar is a notable inventor based in New Brighton, MN (US). He has made significant contributions to the field of immunotherapy, particularly in the culturing of leukocytes. With a total of 2 patents, his work is paving the way for advancements in cancer treatment and immune response enhancement.
Latest Patents
Raji A Shankar's latest patents include an "Immunotherapy protocol of culturing leukocytes in the presence of interleukin-2" and a "Method of culturing leukocytes." The immunotherapy protocol involves culturing leukocytes in a hollow fiber cartridge perfusion system for at least four days. This method achieves a harvest yield of at least 100% of leukocytes compared to the initial number of cells present in the hollow cartridge. The leukocytes produced exhibit lytic activity that is at least equal to that of cells grown in a static culturing system. Similarly, the method for culturing leukocytes also emphasizes the use of a hollow fiber cartridge perfusion system to achieve optimal yields and lytic activity.
Career Highlights
Raji A Shankar is currently associated with Endotronics, Inc., where he continues to innovate in the field of immunotherapy. His work is characterized by a commitment to improving the efficacy of leukocyte cultures, which is crucial for developing effective immunotherapeutic strategies.
Collaborations
Raji collaborates with Georgiann B Melink, contributing to the advancement of their shared goals in immunotherapy research.
Conclusion
Raji A Shankar's contributions to immunotherapy through his innovative patents highlight his role as a key inventor in the field. His work not only enhances our understanding of leukocyte culturing but also holds promise for future therapeutic applications.